1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RBM15B CTRPv2 pan-cancer AAC 0.22 2e-10
mRNA FAM221A CTRPv2 pan-cancer AAC 0.21 3e-10
mRNA EHMT2 CTRPv2 pan-cancer AAC 0.22 3e-10
mRNA ARHGEF7 CTRPv2 pan-cancer AAC 0.21 3e-10
mRNA HNRNPA0 CTRPv2 pan-cancer AAC 0.22 3e-10
mRNA ANGEL2 CTRPv2 pan-cancer AAC 0.21 3e-10
mRNA RFX3 CTRPv2 pan-cancer AAC 0.21 3e-10
mRNA ELAVL1 CTRPv2 pan-cancer AAC 0.22 3e-10
mRNA LMNB1 CTRPv2 pan-cancer AAC 0.22 4e-10
mRNA ZBED4 CTRPv2 pan-cancer AAC 0.24 4e-10
Download CSV